Compare GMED & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | TFX |
|---|---|---|
| Founded | 2003 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 5.4B |
| IPO Year | 2012 | N/A |
| Metric | GMED | TFX |
|---|---|---|
| Price | $93.18 | $125.12 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | $92.42 | ★ $139.88 |
| AVG Volume (30 Days) | ★ 1.3M | 714.0K |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ 358.86 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | $2,769,804,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | $16.86 | $9.90 |
| Revenue Next Year | $8.05 | $10.51 |
| P/E Ratio | $29.38 | ★ N/A |
| Revenue Growth | ★ 11.75 | 5.42 |
| 52 Week Low | $51.79 | $102.58 |
| 52 Week High | $94.93 | $185.94 |
| Indicator | GMED | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 69.71 | 57.53 |
| Support Level | $85.65 | $120.31 |
| Resistance Level | $88.71 | $123.55 |
| Average True Range (ATR) | 1.85 | 3.06 |
| MACD | -0.14 | -0.20 |
| Stochastic Oscillator | 95.89 | 60.67 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.